All questionsIndication: Rinvoq (upadacitinib) in rheumatoid arthritis2 questions · 2 sourcesEligibilityWho is RINVOQ indicated for in rheumatoid arthritis?“RINVOQ is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers.” (opens the source at this quote in a new tab)CopyFlagDrug namesWhat is the generic name of RINVOQ?“RINVOQ® (upadacitinib) extended-release tablets, for oral use” (opens the source at this quote in a new tab)CopyFlag